Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Posts Meager Q3 Revenue Growth as Profit Turns to Loss

NEW YORK (GenomeWeb News) — Affymetrix today reported that revenue for the third quarter increased around 1 percent as last year's profit swung to a loss.
Total receipts for the three months ended Sept. 30 inched up to $84.6 million from $83.4 million year over year
Affy said $59.8 million in revenue during the period came from GeneChip sales while about $10.1 million was made on reagent revenue and $7.7 million from its genotyping services.  
Affy spent $21.6 million on research and development in the quarter, an increase of about 9 percent over last year.
Affy said a $9.4-million profit last year turned into a $14.2-million loss this year. Affy blamed the higher losses primarily on the reduced price of the company’s 500K Mapping Array. The company said it lowered the price in July “ahead of the planned shipments of a single-array 500K in the fourth quarter.”  
The company said it holds $66.5 million in cash and cash equivalents and $179 million in available-for-sale short-term securities.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.